drugset / Trial / NCT07090928

Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures

NCT07090928 ↗

Phase 4 Recruiting 60 enrolled Khyber Teaching Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The investigator's aim is to evaluate the effectiveness of per-operative bupivacaine infiltration at arthroscopic port sites in reducing post-operative pain compared to placebo in patients undergoing knee arthroscopic procedures.

Timeline

Start
2026-03-10
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 5 ml Other

Indications

No indication recorded.